Sarilumab COVID-19

Clinical trial NCT04327388 · COMPLETED

Trial details

NCT number: NCT04327388
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Corona Virus Infection

Start date: 2020-03-28
Primary completion: 2020-07-31
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.